Atlas Trials

A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma

Clinical trial NCT00498043 · COMPLETED

Trial details

NCT number
NCT00498043
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, B-CellLymphoma, Large-Cell, Diffuse
Start date
2007-07-01
Primary completion
2013-10-01
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.